ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Items In This Category

 TitleCreatedDownload
application/pdfDrug Safety Update January 2017.pdf (252KB)20/01/2017Download
  
application/pdfDrug_Safety_Update October 2016.pdf (77KB)19/12/2016Download
 Etoricoxib (Arcoxia): revised dose recommendation for rheumatoid arthritis and ankylosing spondylitis. Letters sent to healthcare professionals in September 2016, including retigabine withdrawal 
application/pdfDrug Safety Update December 2016.pdf (217KB)19/12/2016Download
 Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects. Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially... 
application/pdfDrug Safety Update November_2016.pdf (224KB)11/11/2016Download
 Brimonidine gel (Mirvaso): risk of exacerbation of rosacea. Show your support for reporting suspected adverse drug reactions.  
application/pdfDrug Safety Update September 2016 (290KB)18/10/2016Download
  
application/pdfDrug Safety Update August 2016 (175KB)18/10/2016Download
  
application/pdfDrug Safety Update July 2016 (225KB)18/10/2016Download
  
application/pdfDrug Safety Update June 2016 (277KB)18/10/2016Download
  
application/pdfDrug Safety Update.March 2015 pdf (84KB)18/10/2016Download
  
application/pdfDrug Safety Update.February 2015 pdf (109KB)18/10/2016Download
  
application/pdfDrug Safety Update January 2015 pdf (189KB)18/10/2016Download
  
application/pdfDrug_Safety_Update_-_July_2015_pdf.pdf (221KB)18/10/2016Download
  
Page: [1] [2] [3] [4] [5] [6]